This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Here's Why You Should Retain Tenet Healthcare (THC) Stock
by Zacks Equity Research
Riding high on its strategic measures and cost-cutting methods, Tenet Healthcare (THC) holds enough potential to reap benefits for yield-seeking investors.
HCA Healthcare (HCA) Announces Preliminary Results for Q3
by Zacks Equity Research
HCA Healthcare (HCA) reports preliminary results for the third quarter of 2020. Final results will be released on or around Oct 26.
Here's Why You Should Stay Away From HCA Healthcare Now
by Zacks Equity Research
HCA Healthcare (HCA) business is persistently hurt by the adverse coronavirus impact, which makes it an unattractive bet.
HCA Healthcare, EVERFI's Course to Enhance Behavioral Health
by Zacks Equity Research
HCA Healthcare (HCA) forms alliance with EVERFI, which provides middle and high school students with a digital course to address mental health disorders.
Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC
by Zacks Equity Research
Zacks Industry Outlook Highlights: HCA, UHS, ACHC and THC
Encompass Health Offers Senior Unsecured Notes Worth $400M
by Zacks Equity Research
Encompass Health (EHC) exhibits prudence by issuing senior notes amid a low interest rate environment to procure funds.
Acadia Healthcare Offers Senior Unsecured Notes for $475M
by Zacks Equity Research
Acadia Healthcare (ACHC) exhibits sharp business acumen by issuing senior notes to procure funds.
4 Hospital Stocks to Gain from Improving Admissions, Federal Aid
by Sapna Bagaria
Federal relief, higher admissions and cost containment are likely to aid the Zacks Medical-Hospital industry. HCA, UHS, CYH and THC are well-positioned to gain from a revival in admissions.
Why Should You Retain MEDNAX (MD) in Your Portfolio Now?
by Zacks Equity Research
Riding on restructuring as well as cost-cutting initiatives, MEDNAX (MD) holds potential to reap benefits for investors.
Why Should You Add Universal Health (UHS) to Your Portfolio?
by Zacks Equity Research
Riding high on segmental contributions and a solid balance sheet, Universal Health (UHS) has potential to reap benefits for investors.
Acadia Healthcare, Covenant Health to Offer Mental Healthcare
by Zacks Equity Research
Acadia Healthcare (ACHC) and Covenant Health to unveil East Tennessee Behavioral Health to cater to the mental care services of communities in and around Knoxville.
Why Is Acadia Healthcare (ACHC) Up 0.7% Since Last Earnings Report?
by Zacks Equity Research
Acadia Healthcare (ACHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Hold Strategy is Apt for Acadia Healthcare Stock
by Zacks Equity Research
Acadia Healthcare (ACHC) continues to benefit from increasing demand for telehealth services, strategic buyouts and solid financial position.
Tenet Healthcare Up 39% in a Year: Further Upside Left?
by Zacks Equity Research
Tenet Healthcare's (THC) strategic measures and cost-controlling efforts are expected to support its margins, which in turn, might perk up its share price.
Community Health Up 118.9% in a Year: Further Upside Left?
by Zacks Equity Research
Community Health's (CYH) strategic measures are likely to fetch revenues, which in turn, may bump up its share price.
Acadia Healthcare (ACHC) Q2 Earnings Top Estimates, Fall Y/Y
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q2 earnings are hurt year over year by lower patient days and revenue per patient day, partly offset by decreased expenses.
Acadia Healthcare (ACHC) Beats Q2 Earnings Estimates
by Zacks Equity Research
Acadia Healthcare (ACHC) delivered earnings and revenue surprises of 42.11% and -0.54%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Acadia Healthcare (ACHC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Acadia Healthcare (ACHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ACHC vs. THC: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
ACHC vs. THC: Which Stock Is the Better Value Option?
Magellan's Unit to Improve Behavioral Health of Children
by Zacks Equity Research
Magellan Health's (MGLN) unit - Magellan Healthcare - tied up by which the Mightier program will be available for improving behavioral health outcomes of children.
Centene, Quartet Extend Ties for Mental Health Solutions
by Zacks Equity Research
Centene (CNC) and Quartet Health extend their collaboration to deliver behavioral health care services nationwide.
Acadia Healthcare Opens Mental Health Unit With Tower Health
by Zacks Equity Research
Acadia Healthcare (ACHC) unveils a facility to fortify its foothold in the mental health and behavioral healthcare market.
Are Investors Undervaluing Acadia Healthcare (ACHC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Encompass Health Continues to Strengthen Presence in Florida
by Zacks Equity Research
Encompass Health (EHC) intends to offer improved health outcomes through plans to construct a new hospital in Florida, where it already boasts of a strong base.
ACHC or THC: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
ACHC vs. THC: Which Stock Is the Better Value Option?